» Articles » PMID: 38189837

Bladder Neck Contracture Following Transurethral Surgery of Prostate: a Retrospective Single-center Study

Overview
Journal World J Urol
Specialty Urology
Date 2024 Jan 8
PMID 38189837
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Bladder neck contracture (BNC) is a rare but intolerant complication after transurethral surgery of prostate. The present study aims to investigate the incidence and risk factors of BNC in patients diagnosed benign prostate hyperplasia (BPH) and following transurethral resection or enucleation of the prostate (TURP/TUEP).

Methods: This retrospective study included 1008 BPH individuals who underwent transurethral surgery of the prostate between January 2017 and January 2022. Patients' demographics, medical comorbidities, urologic characteristics, perioperative parameters, and the presence of BNC were documented. Univariate and multivariate analyses were conducted to identify the risk factors.

Results: A total of 2% (20/1008) BPH patients developed BNC postoperatively and the median occurring time was 5.8 months. Particularly, the incidences of BNC were 4.7% and 1.3% in patients underwent Bipolar-TURP and TUEP respectively. Preoperative urinary tract infection (UTI), elevated PSA, smaller prostate volume (PV), bladder diverticulum (BD), and B-TURP were significantly associated with BNC in the univariate analysis. Further multivariate logistic regression demonstrated preoperative UTI (OR 4.04, 95% CI 2.25 to 17.42, p < 0.001), BD (OR 7.40, 95% CI 1.83 to 31.66, p < 0.001), and B-TURP (OR 3.97, 95% CI 1.55 to 10.18, p = 0.004) as independent risk factors. All BNC patients were treated with transurethral incision of the bladder neck (TUIBN) combined with local multisite injection of betamethasone. During a median follow-up of 35.8 months, 35% (7/20) of BNC patients recurred at a median time of 1.8 months.

Conclusion: BNC was a low-frequency complication following transurethral surgery of prostate. Preoperative UTI, BD, and B-TURP were likely independent risk factors of BNC. TUIBN combined with local multisite injection of betamethasone may be promising choice for BNC treatment.

References
1.
Gratzke C, Bachmann A, Descazeaud A, Drake M, Madersbacher S, Mamoulakis C . EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction. Eur Urol. 2015; 67(6):1099-1109. DOI: 10.1016/j.eururo.2014.12.038. View

2.
Launer B, McVary K, Ricke W, Lloyd G . The rising worldwide impact of benign prostatic hyperplasia. BJU Int. 2020; 127(6):722-728. PMC: 8170717. DOI: 10.1111/bju.15286. View

3.
Cornu J, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C . A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update. Eur Urol. 2014; 67(6):1066-1096. DOI: 10.1016/j.eururo.2014.06.017. View

4.
Zhang Y, Yuan P, Ma D, Gao X, Wei C, Liu Z . Efficacy and safety of enucleation vs. resection of prostate for treatment of benign prostatic hyperplasia: a meta-analysis of randomized controlled trials. Prostate Cancer Prostatic Dis. 2019; 22(4):493-508. DOI: 10.1038/s41391-019-0135-4. View

5.
Al-Rawashdah S, Pastore A, Al Salhi Y, Fuschi A, Petrozza V, Maurizi A . Prospective randomized study comparing monopolar with bipolar transurethral resection of prostate in benign prostatic obstruction: 36-month outcomes. World J Urol. 2017; 35(10):1595-1601. DOI: 10.1007/s00345-017-2023-7. View